Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Activity: Talk or presentation typesLecture and oral contribution

    Description

    Current Perspectives and Future Challenges in Gastroenterological-malignancies. National Institutes of Health, GI-Malignancy Faculty, Bethesda USA
    Period2011
    Held atUnknown external organisation